| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0165-6147(00)01863-0 |
| P698 | PubMed publication ID | 11730974 |
| P2093 | author name string | Chizh BA | |
| Tzschentke TM | |||
| Headley PM | |||
| P2860 | cites work | Genetic enhancement of learning and memory in mice | Q22010371 |
| Antinociceptive activity of CP-101,606, an NMDA receptor NR2B subunit antagonist | Q24672789 | ||
| An allosteric interaction between the NMDA receptor polyamine and ifenprodil sites in rat cultured cortical neurones | Q28368825 | ||
| Developmental and regional expression in the rat brain and functional properties of four NMDA receptors | Q28570615 | ||
| Supraspinal vs spinal sites of the antinociceptive action of the subtype-selective NMDA antagonist ifenprodil | Q31679499 | ||
| Genetic enhancement of inflammatory pain by forebrain NR2B overexpression | Q31929803 | ||
| A double-blind, placebo-controlled study of the safety, tolerability and pharmacokinetics of CP-101,606 in patients with a mild or moderate traumatic brain injury | Q33889453 | ||
| (1S,2S)-1-(4-Hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidino)-1-propanol: A Potent New Neuroprotectant Which Blocks N-Methyl-D-Aspartate Responses | Q34302324 | ||
| Pharmacological effects of the non-competitive NMDA antagonist CNS 1102 in normal volunteers | Q34324706 | ||
| Psychotogenicity and N-methyl-D-aspartate receptor antagonism: implications for neuroprotective pharmacotherapy. | Q34415261 | ||
| Peripheral excitatory amino acids | Q34442040 | ||
| Glutamate in CNS disorders as a target for drug development: an update | Q35992523 | ||
| A regulatory domain (R1-R2) in the amino terminus of the N-methyl-D-aspartate receptor: effects of spermine, protons, and ifenprodil, and structural similarity to bacterial leucine/isoleucine/valine binding protein | Q39438768 | ||
| Systemic ketamine attenuates nociceptive behaviors in a rat model of peripheral neuropathy | Q39466007 | ||
| Pharmacological characterization of interactions of RO 25-6981 with the NR2B (epsilon2) subunit | Q40814537 | ||
| Is the discriminative stimulus produced by phencyclidine due to an interaction with N-methyl-D-aspartate receptors? | Q41348274 | ||
| Comparison of ketamine and pethidine in experimental and postoperative pain | Q41350025 | ||
| Effects of a partial agonist and a full antagonist acting at the glycine site of the NMDA receptor on inflammation-induced mechanical hyperalgesia in rats | Q42705294 | ||
| Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues | Q43070521 | ||
| Effects of NMDA receptor antagonists and sigma ligands on the acquisition of conditioned fear in mice | Q44352167 | ||
| Different capability of N-methyl-D-aspartate antagonists to elicit EEG and behavioural phencyclidine-like effects in rats | Q44963581 | ||
| Evaluation of the reinforcing effects of eliprodil in rhesus monkeys and its discriminative stimulus effects in rats | Q45086414 | ||
| Phenylethanolamines inhibit NMDA receptors by enhancing proton inhibition | Q48239991 | ||
| A novel mechanism of activity-dependent NMDA receptor antagonism describes the effect of ifenprodil in rat cultured cortical neurones. | Q48829389 | ||
| Molecular evidence for the involvement of NR2B subunit containing N-methyl-D-aspartate receptors in the development of morphine-induced place preference. | Q49160553 | ||
| Lack of amnestic, psychotomimetic or impairing effect on psychomotor performance of eliprodil, a new NMDA antagonist. | Q51131840 | ||
| Modulation of [3H]MK-801 binding to NMDA receptors in vivo and in vitro. | Q51396890 | ||
| Stimulus intensity, cell excitation and the N-methyl-D-aspartate receptor component of sensory responses in the rat spinal cord in vivo. | Q51537004 | ||
| A novel NMDA antagonist, MK-801, impairs performance in a hippocampal-dependent spatial learning task. | Q52113844 | ||
| Effects of the non-competitive NMDA receptor antagonist ifenprodil on the morphine-induced place preference in mice. | Q52177811 | ||
| Selective NMDA NR2B antagonists induce antinociception without motor dysfunction: correlation with restricted localisation of NR2B subunit in dorsal horn. | Q52535137 | ||
| Potent analgesia induced in rats by combined action at PCP and polyamine recognition sites of the NMDA receptor complex. | Q54050263 | ||
| Blockade of the polyamine site of NMDA receptors produces antinociception and enhances the effect of morphine, in mice | Q63248149 | ||
| The clinically tested N-methyl-D-aspartate receptor antagonist memantine blocks and reverses thermal hyperalgesia in a rat model of painful mononeuropathy | Q71899573 | ||
| Localization of N-methyl-D-aspartate NR2B subunits on primary sensory neurons that give rise to small-caliber sciatic nerve fibers in rats | Q73289187 | ||
| Distinct synaptic and extrasynaptic NMDA receptors identified in dorsal horn neurones of the adult rat spinal cord | Q73552252 | ||
| Enhancement of NMDA-induced current by the putative NR2B selective antagonist ifenprodil | Q73864415 | ||
| Involvement of spinal NMDA receptors in capsaicin-induced nociception | Q74225802 | ||
| [Quality of life of patient with peripheral arterial obliterative disease treated with ifenprodil tartrate. Results of an ARTEMIS study] | Q77652806 | ||
| P433 | issue | 12 | |
| P304 | page(s) | 636-642 | |
| P577 | publication date | 2001-12-01 | |
| P1433 | published in | Trends in Pharmacological Sciences | Q2451474 |
| P1476 | title | NMDA receptor antagonists as analgesics: focus on the NR2B subtype | |
| P478 | volume | 22 |
| Q44345436 | 2-(3,4-Dihydro-1H-isoquinolin-2yl)-pyridines as a novel class of NR1/2B subtype selective NMDA receptor antagonists |
| Q36879280 | A Novel Binding Mode Reveals Two Distinct Classes of NMDA Receptor GluN2B-selective Antagonists |
| Q28593568 | A conditional deletion of the NR1 subunit of the NMDA receptor in adult spinal cord dorsal horn reduces NMDA currents and injury-induced pain |
| Q42837575 | A specific class of interneuron mediates inhibitory plasticity in the lateral amygdala |
| Q34637931 | Abnormal endogenous pain modulation is a shared characteristic of many chronic pain conditions |
| Q37548763 | Allosteric modulators of NR2B-containing NMDA receptors: molecular mechanisms and therapeutic potential |
| Q37405925 | Animal models of pain: progress and challenges |
| Q35204614 | Antagonists and agonists at the glycine site of the NMDA receptor for therapeutic interventions. |
| Q41835834 | Antinociceptive effects of the marine snail peptides conantokin-G and conotoxin MVIIA alone and in combination in rat models of pain |
| Q98735925 | Cardiorespiratory effects of epidurally administered ketamine or lidocaine in dogs undergoing ovariohysterectomy surgery: a comparative study |
| Q36897242 | Cingulate NMDA NR2B receptors contribute to morphine-induced analgesic tolerance |
| Q34129177 | Conantokins derived from the Asprella clade impart conRl-B, an N-methyl d-aspartate receptor antagonist with a unique selectivity profile for NR2B subunits. |
| Q46364124 | Conotoxins: Therapeutic Potential and Application |
| Q45194007 | Cytotoxic effects of exposure to the human immunodeficiency virus type 1 protein Tat in the hippocampus are enhanced by prior ethanol treatment |
| Q36015381 | Discovery of 3-substituted aminocyclopentanes as potent and orally bioavailable NR2B subtype-selective NMDA antagonists |
| Q35047593 | Effect of a neuroprotective drug, eliprodil on cardiac repolarisation: importance of the decreased repolarisation reserve in the development of proarrhythmic risk |
| Q35406724 | Effects of intraoperative low dose ketamine on remifentanil-induced hyperalgesia in gynecologic surgery with sevoflurane anesthesia. |
| Q38292223 | Expert opinion on emerging drugs: chronic low back pain |
| Q40682294 | Expression of functional NR1/NR2B-type NMDA receptors in neuronally differentiated SK-N-SH human cell line |
| Q44881021 | Glutamate and tachykinin receptors in central sensitization of withdrawal reflexes in the decerebrated rabbit. |
| Q28290774 | Glutamate receptor ion channels: structure, regulation, and function |
| Q35124983 | Glutamatergic mechanisms in addiction |
| Q39608585 | Identification of an adenylyl cyclase inhibitor for treating neuropathic and inflammatory pain. |
| Q39481010 | Ifenprodil restores GDNF-evoked Ca(2+) signalling and Na(+)/K(+) -ATPase expression in inflammation-pretreated astrocytes |
| Q48741021 | Influence of memantine on nociceptive responses of the trigeminocervical complex after formalin injection. |
| Q33989582 | Inhibition of G protein-activated inwardly rectifying K+ channels by ifenprodil |
| Q36521957 | Interaction between ephrins/Eph receptors and excitatory amino acid receptors: possible relevance in the regulation of synaptic plasticity and in the pathophysiology of neuronal degeneration. |
| Q42125778 | Intra-cornu ammonis 1 administration of the human immunodeficiency virus-1 protein trans-activator of transcription exacerbates the ethanol withdrawal syndrome in rodents and activates N-methyl-D-aspartate glutamate receptors to produce persisting s |
| Q35069330 | Intracisternal administration of NR2 subunit antagonists attenuates the nociceptive behavior and p-p38 MAPK expression produced by compression of the trigeminal nerve root |
| Q34152988 | Intrathecally administered big dynorphin, a prodynorphin-derived peptide, produces nociceptive behavior through an N-methyl-D-aspartate receptor mechanism |
| Q27004533 | Ion channels as drug targets in central nervous system disorders |
| Q36573180 | Kainate receptor signaling in pain pathways |
| Q48280646 | Ketamine depresses toll-like receptor 3 signaling in spinal microglia in a rat model of neuropathic pain |
| Q33754608 | Left-right asymmetry defect in the hippocampal circuitry impairs spatial learning and working memory in iv mice |
| Q46875386 | Linalool and linalool complexed in β-cyclodextrin produce anti-hyperalgesic activity and increase Fos protein expression in animal model for fibromyalgia |
| Q36860042 | Low dose ketamine: a therapeutic and research tool to explore N-methyl-D-aspartate (NMDA) receptor-mediated plasticity in pain pathways |
| Q44067007 | Mapping the binding site of the neuroprotectant ifenprodil on NMDA receptors. |
| Q28577591 | Mapping the high-affinity binding domain of 5-substituted benzimidazoles to the proximal N-terminus of the GluN2B subunit of the NMDA receptor |
| Q55514073 | NMDA receptor antagonists attenuate intrathecal morphine-induced pruritus through ERK phosphorylation. |
| Q26997407 | NMDA receptor modulators: an updated patent review (2013-2014) |
| Q34982270 | NMDA receptor pathways as drug targets |
| Q28565516 | NMDA receptor subunit-dependent [Ca2+] signaling in individual hippocampal dendritic spines |
| Q35841040 | NMDA receptors are expressed in human ovarian cancer tissues and human ovarian cancer cell lines |
| Q37346338 | NR2B Expression in Rat DRG Is Differentially Regulated Following Peripheral Nerve Injuries That Lead to Transient or Sustained Stimuli-Evoked Hypersensitivity |
| Q34280777 | NR2B containing NMDA receptor dependent windup of single spinal neurons. |
| Q42441852 | Neuronal major histocompatibility complex class I molecules are implicated in the generation of asymmetries in hippocampal circuitry. |
| Q34719359 | Neuropharmacologic targets and agents in fibromyalgia |
| Q35100294 | New developments in the treatment of functional dyspepsia |
| Q37553194 | Nociceptive behavior induced by the endogenous opioid peptides dynorphins in uninjured mice: evidence with intrathecal N-ethylmaleimide inhibiting dynorphin degradation |
| Q44363647 | Novel N1-(benzyl)cinnamamidine derived NR2B subtype-selective NMDA receptor antagonists |
| Q44363651 | Orally efficacious NR2B-selective NMDA receptor antagonists |
| Q34004576 | Pain mechanisms and their implication for the management of pain in farm and companion animals |
| Q41542412 | Peripheral inflammation activated focal adhesion kinase signaling in spinal dorsal horn of mice |
| Q36396058 | PirB regulates asymmetries in hippocampal circuitry |
| Q35950461 | Prolonged maintenance of capsaicin-induced hyperalgesia by brief daily vibration stimuli |
| Q44939731 | Protective effect of ifenprodil against spreading depression in the mouse entorhinal cortex |
| Q92125043 | Protein Kinase C Lambda Mediates Acid-Sensing Ion Channel 1a-Dependent Cortical Synaptic Plasticity and Pain Hypersensitivity |
| Q34249621 | RF9, a potent and selective neuropeptide FF receptor antagonist, prevents opioid-induced tolerance associated with hyperalgesia |
| Q33328469 | Right isomerism of the brain in inversus viscerum mutant mice |
| Q36499757 | Role of altered structure and function of NMDA receptors in development of alcohol dependence |
| Q45174200 | Selective subunit antagonists suggest an inhibitory relationship between NR2B and NR2A-subunit containing N-methyl-D: -aspartate receptors in hippocampal slices |
| Q44617805 | Subunit-dependent effects of nickel on NMDA receptor channels |
| Q46885932 | Switch to Ca2+-permeable AMPA and reduced NR2B NMDA receptor-mediated neurotransmission at dorsal horn nociceptive synapses during inflammatory pain in the rat. |
| Q34037539 | Synaptic GluN2A and GluN2B containing NMDA receptors within the superficial dorsal horn activated following primary afferent stimulation |
| Q46099721 | Targeting pain where it resides ... In the brain |
| Q37374352 | Targeting the NMDA receptor subunit NR2B for the treatment of neuropathic pain |
| Q38242753 | Targeting the NMDA receptor subunit NR2B for treating or preventing age-related memory decline |
| Q35031245 | The N-methyl-D-aspartate receptor subunit NR2B: localization, functional properties, regulation, and clinical implications. |
| Q43935135 | The NR2B subunit of glutamate receptors as a potential target for relieving chronic pain: prospects and concerns |
| Q35538562 | The Role of N-Methyl-d-Aspartate (NMDA) Receptors in Pain: A Review |
| Q48320720 | The Structure-Activity Relationship of a Tetrahydroisoquinoline Class of N-Methyl-d-Aspartate Receptor Modulators that Potentiates GluN2B-Containing N-Methyl-d-Aspartate Receptors. |
| Q44582079 | The effect of (+/-)-CP-101,606, an NMDA receptor NR2B subunit selective antagonist, in the Morris watermaze |
| Q34512150 | The external globus pallidus: progress and perspectives |
| Q35202929 | The neurobiology and control of anxious states |
| Q44454428 | Unaltered pain-related behavior in mice lacking NMDA receptor GluRepsilon 1 subunit |
| Q47304491 | Variations of isovaline structure related to activity in the formalin foot assay in mice. |
Search more.